\-\ Texto\\:\\ \ \(0\)\
\-\ treatment\\:\\ \ \(2\)\
\-\ grade\\ \\ \\ \\	\\	\\ \\ \\ \\ \\ \\ \\ \\ \\ \ \(0\)\
\-\ i\\-ii\\	initial\\ rx\\:\\ antibiotic\\ prophylaxis\ \(0\)\
\-\ \\_\\_\\_\\_follow\\ up\\ rx\\:\\ no\\ consensus\ \(0\)\
\-\ iii\\-iv\\	initial\\ rx\\:\\ antibiotic\\ prophylaxis\ \(0\)\
\-\ \\_\\_\\_\\_\\_\\_if\\ \\>6yrs\\ \\&\\ bilateral\\:\\ surgery\\	\\	\\ \ \(0\)\
\-\ \\_\\_\\_\\_\\_\\_follow\\ up\\ rx\\:\\ surgery\ \(0\)\
\-\ v\\	initial\\ rx\\:\\ \\<1yrs\\ \\-\\ antibiotic\\ prophylaxis\ \(0\)\
\-\ \\_\\_1\\-5yrs\\ \\&\\ unilateral\\:\\ antibiotic\\ prophylaxis\ \(0\)\
\-\ \\_\\_1\\-5yrs\\ \\&\\ bilateral\\ or\\ renal\\ scarring\\ present\\:\\ surgery\ \(0\)\
\-\ \\_\\_\\>6yrs\\:\\ surgery\ \(0\)\
\-\ \\_\\_follow\\ up\\ rx\\:\\ surgery\ \(0\)\
\-\ non\\ surgical\\ management\\ includes\\ urine\\ cultures\\ every\\ 4\\ months\\ \\&\\ when\\ febrile\\,\\ as\\ well\\ as\\ antibiotic\\ prophylaxis\\.\\ \\ amoxicillin\\ is\\ recommended\\ in\\ infants\\ less\\ than\\ 2\\ months\\ of\\ age\\,\\ trimethoprim\\-sulfamethoxazole\\ or\\ nitrofurantoin\\ in\\ children\\ greater\\ than\\ 2\\ months\\.\\ \\ if\\ vur\\ has\\ not\\ resolved\\ within\\ 12\\-18\\ months\\ or\\ breakthrough\\ pyelonephritis\\ occurs\\ while\\ on\\ prophylaxis\\,\\ surgical\\ correction\\ is\\ indicated\\.\ \(0\)\
\-\ vcug\\ findings\\:\ \(0\)\
\-\ early\\ filling\\ views\\ demonstrated\\ no\\ filling\\ defects\\ or\\ ureteroceles\\.\\ \\ there\ \(0\)\
\-\ was\\ bilateral\\ vesicoureteral\\ reflux\\ to\\ the\\ level\\ of\\ the\\ collecting\\ systems\\,\ \(1\)\
\-\ left\\ greater\\ than\\ right\\.\\ \\ there\\ was\\ mild\\ dilatation\\ of\\ the\\ collecting\\ system\ \(0\)\
\-\ as\\ well\\ as\\ blunting\\ of\\ the\\ calyces\\.\\ \\ the\\ patient\\ spontaneously\\ voided\\.\\ \ \(0\)\
\-\ post\\-void\\ images\\ continued\\ to\\ demonstrate\\ contrast\\ within\\ the\\ ureters\ \(0\)\
\-\ and\\ collecting\\ system\\ as\\ well\\ as\\ bladder\\.\ \(1\)\
\-\ \\ \ \(1082074\)\
\-\ impression\\:\ \(2\)\
\-\ bilateral\\ grade\\ iii\\ vesicoureteral\\ reflux\\,\\ slightly\\ worse\\ on\\ the\\ left\\.\ \(0\)\
\-\ vesicoureteral\\ reflux\\ \\(grade\\ iii\\)\ \(0\)\
\-\ 8\\ wk\\ old\\ female\\ with\\ left\\ renal\\ caliectasis\\ \\(8mm\\)\\ diagnosed\\ on\\ prenatal\\ us\\,\\ resolved\\ to\\ 6mm\\ on\\ us\\ at\\ 6wks\\ of\\ life\ \(0\)\
\-\ vesicoureteral\\ reflux\\(vur\\)\ \(0\)\
\-\ definition\\ \\â\\€\\“\\ retrograde\\ flow\\ of\\ urine\\ from\\ the\\ bladder\\ into\\ the\\ upper\\ urinary\\ tract\\.\ \(0\)\
\-\ grade\\ i\\ \\:\\ ureter\\ only\ \(0\)\
\-\ grade\\ ii\\:\\ ureter\\,\\ pelvis\\,\\ calyces\\;\\ no\\ dilation\\,\\ normal\\ calyceal\\ fornices\ \(0\)\
\-\ grade\\ iii\\:\\ \\ mild\\ dilation\\ of\\ ureter\\;\\ mild\\ or\\ moderate\\ dilation\\ of\\ the\\ pelvis\\,\\ but\\ minimal\\ blunting\\ of\\ the\\ fornices\\.\ \(0\)\
\-\ grade\\ iv\\:\\ moderate\\ dilation\\ of\\ the\\ ureter\\;\\ mild\\ dilation\\ of\\ renal\\ pelvis\\ and\\ calyces\\;\\ complete\\ obliteration\\ of\\ sharp\\ angle\\ of\\ fornices\\,\\ but\\ maintenance\\ of\\ papillary\\ impressions\\ in\\ majority\\ of\\ calyces\ \(0\)\
\-\ grade\\ v\\:\\ gross\\ dilation\\ and\\ tortuosity\\ of\\ ureter\\;\\ gross\\ dilation\\ of\\ renal\\ pelvis\\ and\\ calyces\\;\\ papillary\\ impressions\\ are\\ no\\ longer\\ visible\\ in\\ majority\\ of\\ calyces\ \(0\)\
\-\ significance\\ \\â\\€\\“\\ retrograde\\ flow\\ of\\ urine\\ from\\ the\\ bladder\\ to\\ the\\ upper\\ urinary\\ tract\\ facilitates\\ the\\ transport\\ of\\ bacteria\\.\\ \\ this\\ results\\ in\\ a\\ predisposition\\ to\\ pyelonephritis\\.\\ \\ multiple\\ episodes\\ of\\ pyelonephritis\\ leads\\ to\\ renal\\ scarring\\ resulting\\ in\\ complications\\ such\\ as\\ renal\\ insufficiency\\ and\\ hypertension\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ rx\\:\\ 0\\.0917479967272246\ \(0\)\
\-\ calyces\\:\\ 0\\.08231919142083115\ \(0\)\
\-\ prophylaxis\\:\\ 0\\.07753308001690973\ \(0\)\
\-\ dilation\\:\\ 0\\.0681067313243748\ \(0\)\
\-\ grade\\:\\ 0\\.06289539696523613\ \(0\)\
\-\ ureter\\:\\ 0\\.0556863019876272\ \(0\)\
\-\ antibiotic\\:\\ 0\\.05281240540430171\ \(0\)\
\-\ vesicoureteral\\:\\ 0\\.05055071966676704\ \(0\)\
\-\ \\:\\:\\ 0\\.04914238330394196\ \(0\)\
\-\ fornices\\:\\ 0\\.04881215132091784\ \(0\)\
\-\ 6yrs\\:\\ 0\\.042587045526408206\ \(0\)\
\-\ \\_\\_1\\-5yrs\\:\\ 0\\.042587045526408206\ \(0\)\
\-\ impressions\\:\\ 0\\.039238508422253876\ \(0\)\
\-\ reflux\\:\\ 0\\.03814477269092672\ \(0\)\
\-\ renal\\:\\ 0\\.037209790571856076\ \(0\)\
\-\ pyelonephritis\\:\\ 0\\.03613679005418408\ \(0\)\
\-\ vur\\:\\ 0\\.03318651340536804\ \(0\)\
\-\ collecting\\:\\ 0\\.03160268933125355\ \(0\)\
\-\ pelvis\\:\\ 0\\.03000088315547467\ \(0\)\
\-\ urine\\:\\ 0\\.02988529378070547\ \(0\)\
\-\ \\;\\:\\ 0\\.029353930267428895\ \(0\)\
\-\ iii\\:\\ 0\\.029068821588646678\ \(0\)\
\-\ \\&\\:\\ 0\\.028998916832284363\ \(0\)\
\-\ blunting\\:\\ 0\\.027654473287962233\ \(0\)\
\-\ bladder\\:\\ 0\\.025133412269920503\ \(0\)\
\-\ surgery\\:\\ 0\\.02506037517343327\ \(0\)\
\-\ retrograde\\:\\ 0\\.02476637183503653\ \(0\)\
\-\ scarring\\:\\ 0\\.024091193369456053\ \(0\)\
\-\ v\\:\\ 0\\.02264919825565897\ \(0\)\
\-\ months\\:\\ 0\\.022550157436619006\ \(0\)\
\-\ as\\:\\ 0\\.02185517522043211\ \(0\)\
\-\ mild\\:\\ 0\\.02174157926503514\ \(0\)\
\-\ i\\-ii\\:\\ 0\\.021293522763204103\ \(0\)\
\-\ \\_\\_\\_\\_follow\\:\\ 0\\.021293522763204103\ \(0\)\
\-\ \\_\\_\\_\\_\\_\\_if\\:\\ 0\\.021293522763204103\ \(0\)\
\-\ \\_\\_\\_\\_\\_\\_follow\\:\\ 0\\.021293522763204103\ \(0\)\
\-\ 1yrs\\:\\ 0\\.021293522763204103\ \(0\)\
\-\ \\_\\_\\:\\ 0\\.021293522763204103\ \(0\)\
\-\ \\_\\_follow\\:\\ 0\\.021293522763204103\ \(0\)\
\-\ trimethoprim\\-sulfamethoxazole\\:\\ 0\\.021293522763204103\ \(0\)\
\-\ voided\\:\\ 0\\.021293522763204103\ \(0\)\
\-\ papillary\\:\\ 0\\.02095739907965358\ \(0\)\
\-\ initial\\:\\ 0\\.02051871118318339\ \(0\)\
\-\ majority\\:\\ 0\\.020291777329107433\ \(0\)\
\-\ bilateral\\:\\ 0\\.020036886273569508\ \(0\)\
\-\ resolved\\:\\ 0\\.020012993186012518\ \(0\)\
\-\ gross\\:\\ 0\\.01966466809470168\ \(0\)\
\-\ iii\\-iv\\:\\ 0\\.019619254211126938\ \(0\)\
\-\ 12\\-18\\:\\ 0\\.019619254211126938\ \(0\)\
\-\ caliectasis\\:\\ 0\\.019619254211126938\ \(0\)\
\-\ urinary\\:\\ 0\\.01910969091596534\ \(0\)\
\-\ nitrofurantoin\\:\\ 0\\.018639869892025093\ \(0\)\
\-\ ureteroceles\\:\\ 0\\.018639869892025093\ \(0\)\
\-\ 6wks\\:\\ 0\\.018639869892025093\ \(0\)\
\-\ facilitates\\:\\ 0\\.018639869892025093\ \(0\)\
\-\ \\â\\€\\“\\:\\ 0\\.018578285625074867\ \(0\)\
\-\ tract\\:\\ 0\\.018285413055913344\ \(0\)\
\-\ post\\-void\\:\\ 0\\.01740599157374975\ \(0\)\
\-\ us\\:\\ 0\\.017315989406337735\ \(0\)\
\-\ up\\:\\ 0\\.016651066311987126\ \(0\)\
\-\ filling\\:\\ 0\\.016619516986871172\ \(0\)\
\-\ amoxicillin\\:\\ 0\\.01659325670268402\ \(0\)\
\-\ wk\\:\\ 0\\.01659325670268402\ \(0\)\
\-\ system\\:\\ 0\\.016253526427056995\ \(0\)\
\-\ moderate\\:\\ 0\\.01623283723965602\ \(0\)\
\-\ than\\:\\ 0\\.016224991702306332\ \(0\)\
\-\ breakthrough\\:\\ 0\\.015986217020846082\ \(0\)\
\-\ transport\\:\\ 0\\.01573172302167259\ \(0\)\
\-\ predisposition\\:\\ 0\\.01573172302167259\ \(0\)\
\-\ greater\\:\\ 0\\.015505876124012082\ \(0\)\
\-\ tortuosity\\:\\ 0\\.015291332787870766\ \(0\)\
\-\ consensus\\:\\ 0\\.01509799291426319\ \(0\)\
\-\ 8mm\\:\\ 0\\.014918988150606858\ \(0\)\
\-\ maintenance\\:\\ 0\\.014918988150606858\ \(0\)\
\-\ calyceal\\:\\ 0\\.014752338702570743\ \(0\)\
\-\ well\\:\\ 0\\.014007832992526456\ \(0\)\
\-\ obliteration\\:\\ 0\\.013827236643981116\ \(0\)\
\-\ \\>\\:\\ 0\\.01371578509501722\ \(0\)\
\-\ flow\\:\\ 0\\.013642772351973507\ \(0\)\
\-\ 6mm\\:\\ 0\\.013518460384295404\ \(0\)\
\-\ vcug\\:\\ 0\\.013332564149667075\ \(0\)\
\-\ significance\\:\\ 0\\.013159957956473487\ \(0\)\
\-\ definition\\:\\ 0\\.01307807015049358\ \(0\)\
\-\ bacteria\\:\\ 0\\.01307807015049358\ \(0\)\
\-\ ureters\\:\\ 0\\.012705725513229672\ \(0\)\
\-\ or\\:\\ 0\\.01209568537395782\ \(0\)\
\-\ infants\\:\\ 0\\.011993649329121834\ \(0\)\
\-\ febrile\\:\\ 0\\.01189299064216394\ \(0\)\
\-\ correction\\:\\ 0\\.01179635939913568\ \(0\)\
\-\ spontaneously\\:\\ 0\\.011658295597589912\ \(0\)\
\-\ longer\\:\\ 0\\.011658295597589912\ \(0\)\
\-\ leads\\:\\ 0\\.01152769844476316\ \(0\)\
\-\ prenatal\\:\\ 0\\.011210461724808841\ \(0\)\
\-\ sharp\\:\\ 0\\.011173583772802106\ \(0\)\
\-\ impression\\:\\ 0\\.011031456961152509\ \(0\)\
\-\ every\\:\\ 0\\.010963411364614596\ \(0\)\
\-\ systems\\:\\ 0\\.010963411364614596\ \(0\)\
\-\ insufficiency\\:\\ 0\\.010963411364614596\ \(0\)\
\-\ cultures\\:\\ 0\\.010619994725048067\ \(0\)\
\-\ unilateral\\:\\ 0\\.010243496245079989\ \(0\)\
\-\ episodes\\:\\ 0\\.010194199453700262\ \(0\)\
\-\ upper\\:\\ 0\\.009961741571829557\ \(0\)\
\-\ visible\\:\\ 0\\.009770129950485104\ \(0\)\
\-\ angle\\:\\ 0\\.009689607196215559\ \(0\)\
\-\ defects\\:\\ 0\\.009481085255422088\ \(0\)\
\-\ worse\\:\\ 0\\.009142706527956672\ \(0\)\
\-\ resulting\\:\\ 0\\.009065032345264568\ \(0\)\
\-\ life\\:\\ 0\\.009004642726410904\ \(0\)\
\-\ indicated\\:\\ 0\\.00893121886847764\ \(0\)\
\-\ children\\:\\ 0\\.008916798175273523\ \(0\)\
\-\ ii\\:\\ 0\\.008902463065322282\ \(0\)\
\-\ 2\\:\\ 0\\.008889393702949498\ \(0\)\
\-\ continued\\:\\ 0\\.008888212528783178\ \(0\)\
\-\ dilatation\\:\\ 0\\.008845958525286761\ \(0\)\
\-\ but\\:\\ 0\\.008804363773108876\ \(0\)\
\-\ surgical\\:\\ 0\\.008677399856287215\ \(0\)\
\-\ recommended\\:\\ 0\\.008556808853629834\ \(0\)\
\-\ non\\:\\ 0\\.008532161099585772\ \(0\)\
\-\ i\\:\\ 0\\.008532161099585772\ \(0\)\
\-\ views\\:\\ 0\\.008507762317009676\ \(0\)\
\-\ occurs\\:\\ 0\\.008471620112476553\ \(0\)\
\-\ slightly\\:\\ 0\\.008343541686611286\ \(0\)\
\-\ results\\:\\ 0\\.008332228040929097\ \(0\)\
\-\ includes\\:\\ 0\\.008320967139707331\ \(0\)\
\-\ no\\:\\ 0\\.008313470055109198\ \(0\)\
\-\ complications\\:\\ 0\\.008179161340608834\ \(0\)\
\-\ hypertension\\:\\ 0\\.008137152300242\ \(0\)\
\-\ minimal\\:\\ 0\\.008126763213528497\ \(0\)\
\-\ \\<\\:\\ 0\\.007966341853869059\ \(0\)\
\-\ within\\:\\ 0\\.007875030958386868\ \(0\)\
\-\ management\\:\\ 0\\.007788723293371114\ \(0\)\
\-\ 8\\:\\ 0\\.007717675261471856\ \(0\)\
\-\ diagnosed\\:\\ 0\\.007589843373900979\ \(0\)\
\-\ early\\:\\ 0\\.0075486931633875305\ \(0\)\
\-\ iv\\:\\ 0\\.007532427385171724\ \(0\)\
\-\ complete\\:\\ 0\\.007264193077261001\ \(0\)\
\-\ \\,\\:\\ 0\\.0071927795185752685\ \(0\)\
\-\ on\\:\\ 0\\.00699411606150172\ \(0\)\
\-\ less\\:\\ 0\\.006990193247156237\ \(0\)\
\-\ left\\:\\ 0\\.006928299052702281\ \(0\)\
\-\ while\\:\\ 0\\.006494321835392061\ \(0\)\
\-\ such\\:\\ 0\\.006452494661451333\ \(0\)\
\-\ age\\:\\ 0\\.00628239209068673\ \(0\)\
\-\ only\\:\\ 0\\.006206308353828347\ \(0\)\
\-\ to\\:\\ 0\\.006189392875985308\ \(0\)\
\-\ there\\:\\ 0\\.006143553412874341\ \(0\)\
\-\ from\\:\\ 0\\.006118046923450301\ \(0\)\
\-\ in\\:\\ 0\\.006107206233916738\ \(0\)\
\-\ demonstrated\\:\\ 0\\.006056570005934704\ \(0\)\
\-\ level\\:\\ 0\\.00594900731315684\ \(0\)\
\-\ when\\:\\ 0\\.005911428110183589\ \(0\)\
\-\ of\\:\\ 0\\.005909613083955935\ \(0\)\
\-\ 4\\:\\ 0\\.005751139867582235\ \(0\)\
\-\ if\\:\\ 0\\.0056008295501947716\ \(0\)\
\-\ \\(\\:\\ 0\\.005234505262636671\ \(0\)\
\-\ \\)\\:\\ 0\\.005170562986328298\ \(0\)\
\-\ the\\:\\ 0\\.0050090320544791955\ \(0\)\
\-\ into\\:\\ 0\\.004911416347728761\ \(0\)\
\-\ was\\:\\ 0\\.004774287546926023\ \(0\)\
\-\ demonstrate\\:\\ 0\\.004749884399355171\ \(0\)\
\-\ present\\:\\ 0\\.004661856893554785\ \(0\)\
\-\ contrast\\:\\ 0\\.004620231127555326\ \(0\)\
\-\ \\-\\:\\ 0\\.0044244648761071585\ \(0\)\
\-\ findings\\:\\ 0\\.0043933259318598055\ \(0\)\
\-\ multiple\\:\\ 0\\.004347357496326736\ \(0\)\
\-\ female\\:\\ 0\\.004243382298183173\ \(0\)\
\-\ treatment\\:\\ 0\\.004177818742997311\ \(0\)\
\-\ images\\:\\ 0\\.0039595746182351545\ \(0\)\
\-\ has\\:\\ 0\\.0038760868852518787\ \(0\)\
\-\ normal\\:\\ 0\\.003235778875843239\ \(0\)\
\-\ not\\:\\ 0\\.0029826537964781044\ \(0\)\
\-\ are\\:\\ 0\\.002813705006110149\ \(0\)\
\-\ at\\:\\ 0\\.00279652935466578\ \(0\)\
\-\ is\\:\\ 0\\.002716380571906887\ \(0\)\
\-\ this\\:\\ 0\\.002321587471773268\ \(0\)\
\-\ right\\:\\ 0\\.002177854369831924\ \(0\)\
\-\ and\\:\\ 0\\.002174021808360126\ \(0\)\
\-\ old\\:\\ 0\\.002113368591454721\ \(0\)\
\-\ patient\\:\\ 0\\.002069062635063739\ \(0\)\
\-\ \\.\\:\\ 0\\.0012004674042580864\ \(0\)\
\-\ a\\:\\ 0\\.0009579705357937228\ \(0\)\
\-\ with\\:\\ 0\\.0002826187828258206\ \(0\)\
